Evidence map›Paper›PMID 40109734›Full record

ArticleACS pharmacology & translational science2025

Julian Guercetti, Marc Alorda, Luciano Sappia, Roger Galve, Macarena Duran-Corbera, Daniel Pulido, Ginevra Berardi, Miriam Royo, Alicia Lacoma, José Muñoz and 8 more

Abstract read
In one paragraph

Article in ACS pharmacology & translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Julian GuercettiNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.
Marc AlordaNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.
Luciano SappiaNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.
Roger GalveNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.ORCID https://orcid.org/0000-0001-6189-5037
Macarena Duran-CorberaMultivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.
Daniel PulidoMultivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.ORCID https://orcid.org/0000-0002-2841-194X
Ginevra BerardiMultivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.
Miriam RoyoMultivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.ORCID https://orcid.org/0000-0001-5292-0819
Alicia LacomaServei de Microbiologia, Hospital Universitari Germans Trias i Pujol, Institut Germans Trias i Pujol, 08916 Badalona, Spain.ORCID https://orcid.org/0000-0002-2049-3872
José MuñozServicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain.
Eduardo PadillaServicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain.
Silvia CastañedaServicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.
Elena SendraServicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.ORCID https://orcid.org/0000-0002-4374-2173
Juan P HorcajadaServicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.
Agustín Gutierrez-GalvezInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.
Santiago MarcoInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.
J-Pablo SalvadorNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.ORCID https://orcid.org/0000-0002-3608-0634
M-Pilar MarcoNanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.ORCID https://orcid.org/0000-0002-4064-1668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multiplexed microarray chip (

Identifiers

PMID40109734
PMCPMC11915183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.